Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience.
Lara ColussiArianna DagriSerena PastoreAlberto TommasiniAlessia PinAndrea TaddioPublished in: International journal of rheumatic diseases (2024)